رجوع
نطاق اليوم
KWD 243.18
KWD 252.83
نطاق 52 أسبوعًا
KWD 122.80
KWD 298.30
حجم التداول
271,518
متوسط 50 يوم / 200 يوم
KWD 269.80
/
KWD 199.95
الإغلاق السابق
KWD 250.08
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 35.3 | 0.4 |
| P/B | 5.9 | 2.9 |
| ROE % | 18.9 | 3.7 |
| Net Margin % | 52.6 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 311.000
+25.9%
Low: KWD 224.000
High: KWD 371.000
مكرر الربحية المستقبلي
32.5
ربحية السهم المستقبلية
KWD 7.703
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
530 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 27.114
KWD 20.968 – KWD 34.600
|
1.5 B | 1 |
| FY2029 |
KWD 20.298
KWD 15.697 – KWD 25.902
|
1.1 B | 1 |
| FY2028 |
KWD 13.455
KWD 8.344 – KWD 27.132
|
900 M | 5 |
النقاط الرئيسية
Earnings grew 129.74% over the past year
ROE of 18.91% — decent returns on equity
Net margin of 52.64% shows strong profitability
Debt/Equity of 0.01 — conservative balance sheet
Generating 188.91M in free cash flow
P/E of 35.26 — premium valuation
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)33.94%
Earnings (1Y)129.74%
FCF Growth (3Y)N/A
الجودة
Return on Equity
18.91%
ROIC9.84%
Net Margin52.64%
Op. Margin41.45%
الأمان
Debt / Equity
0.01
Current Ratio9.95
Interest Coverage0.00
التقييم
P/E Ratio
35.26
P/B Ratio5.92
EV/EBITDA41.76
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 33.94% | Revenue Growth (3Y) | 177.04% |
| Earnings Growth (1Y) | 129.74% | Earnings Growth (3Y) | 332.86% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 389.13M | Net Income (TTM) | 204.83M |
| ROE | 18.91% | ROA | 15.36% |
| Gross Margin | 92.61% | Operating Margin | 41.45% |
| Net Margin | 52.64% | Free Cash Flow (TTM) | 188.91M |
| ROIC | 9.84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 9.95 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 35.26 | P/B Ratio | 5.92 |
| P/S Ratio | 18.56 | PEG Ratio | 0.27 |
| EV/EBITDA | 41.76 | Dividend Yield | 0.00% |
| Market Cap | 7.22B | Enterprise Value | 6.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 389.13M | 290.52M | 50.70M | 0.0 | 0.0 |
| Net Income | 204.83M | 89.16M | 10.93M | -139.98M | -69.57M |
| EPS (Diluted) | 6.84 | 3.00 | 0.39 | -5.49 | -3.13 |
| Gross Profit | 360.36M | 270.45M | 47.61M | 0.0 | 0.0 |
| Operating Income | 161.30M | 65.70M | -109.73M | -145.20M | -68.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.33B | 1.06B | 818.36M | 558.45M | 626.30M |
| Total Liabilities | 114.23M | 109.46M | 39.71M | 36.22M | 32.72M |
| Shareholders' Equity | 1.22B | 946.38M | 778.64M | 522.23M | 593.58M |
| Total Debt | 9.34M | 7.26M | 8.09M | 8.93M | 8.02M |
| Cash & Equivalents | 496.30M | 344.87M | 358.33M | 161.90M | 341.25M |
| Current Assets | 1.02B | 742.05M | 587.91M | 383.78M | 442.27M |
| Current Liabilities | 102.94M | 102.00M | 33.09M | 28.85M | 25.74M |